Cell Medica

Cell Medica is committed to improving patients’ lives through the significant therapeutic potential of cellular immunotherapy. Our approach is to apply innovative technologies with the aim of improving the treatment of cancer. We have developed a business platform that has positioned Cell Medica as a leader in the manufacture and commercialization of cellular products. We collaborate with leading academic institutions to turn early stage innovations into medicinal products. Our highly dedicated team embrace the challenges that the field of cellular therapies presents. With patient benefits at the forefront of our activities, we overcome the considerable challenges through collaboration and the will to succeed.

C-Suite On Deck

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Events

13TH IASR INTERNATIONAL CONFERENCE ON FORENSIC SCIENCE

Conference

International Conference on Oil, Gas and Petroleum Engineering

Conference

Improving Vehicle Safety in the Waste and Recycling Sector

Webinar

Chemistry and Catalysis 5th World Congress on

Webinar

5TH WORLD CHEMISTRY CONFERENCE AND EXHIBITION (WCCE-2022)

Conference

Carbon Chemistry and Materials (CCM-2022)

Conference

Related News

CHEMICAL TECHNOLOGY

SAGA PURE ASA INVESTS NOK 30 MILLION IN THE CHEMICAL RECYCLING COMPANY PRYME

Saga Pure ASA | January 25, 2021

Saga Pure ASA has as a foundation financial specialist, resolved to buy in and be dispensed offers for NOK 30 million out of a private position of new offers in CRC Holding B.V ("Pryme"). Following the Private Placement Saga will claim around 4% of the organization. “Over the last few years the world has come to truly understand the negative impacts plastic waste has on the ecosystems, and there is a strong need for innovative solutions to tackle the issue. One imp...

CHEMICAL TECHNOLOGY

KBR AWARDED CHEMICALS TECHNOLOGY CONTRACT BY HANWHA

KBR | October 14, 2021

KBR (NYSE: KBR) announced today it has been awarded a dual-pressure nitric acid technology contract by Hanwha Corp. for its new plant at Yeosu, South Korea. Under the terms of the contract, KBR will provide license, basic engineering design, and technical support to Hanwha for a 1,200 metric tons per day dual pressure nitric acid plant. Nitric acid is an intermediate chemical for the production of various products including fertilizers, plastics, and dyes. Read More

CHEMICAL MANAGEMENT

ENERGY SERVICES OF AMERICA ANNOUNCES ACQUISITION

Energy Services of America Corporation | April 07, 2022

Energy Services of America Corporation formed a newly wholly owned subsidiary Tri-State Paving Acquisition Company, Inc., a West Virginia corporation, which has entered into an Asset Purchase Agreement with Tri-State Paving & Sealcoating, LLC a West Virginia corporation located in Hurricane, West Virginia to acquire substantially all of the assets of Tri-State Paving for $7.5 million in cash, a $1.0 million seller note, and $1.0 million in the Company's common stock. The Company expects ...

SUSTAINABILITY RANKINGS OF CHEMICAL COMPANIES UNVEILED

Bio Market Insights | June 22, 2020

Environmental NGO ChemSec has unveiled a new corporate benchmarking tool that measures the chemical footprint of 35 of the world’s largest chemical companies and found that European countries topped the sustainability list. The new tool is called ChemScore. Through ChemScore, investors can access data on the best and worst performers in the chemical industry based on the amount of hazardous chemicals they produce and their efforts to transition to safer, green...

CHEMICAL TECHNOLOGY